FindTrial
Sign In

Outcome of Diaphragmatic function after interscalene brachial plexus block

Evaluation of diaphragmatic function after interscalene brachial plexus block with low dose bupivacaine and saline hydrodissection of phrenic nerve - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074492
Enrollment
40
Registered
2024-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Bupivacaine 0.5% 15ml through brachial plexus nerve block: Total duration 18 months Control Intervention1: Bupivacaine 0.5% 15ml with 10ml normal saline through brachial plexus nerve bl

Sponsors

Sri devaraj urs Academy of Higher education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA class1-3 Undergoing elective surgeries on humerus,clavicle,shoulder

Exclusion criteria

Exclusion criteria: Patient refusal Allergy to local anaesthetic Severe coagulopathy Local infection Pregnancy Moderate to severe pulmonary dysfunction

Design outcomes

Primary

MeasureTime frame
To determine incidence of phrenic nerve paresisTimepoint: To determine incidence of phrenic nerve paresis for each patient at baseline, 6 hours and 24 hours post operatively—

Secondary

MeasureTime frame
To evaluate the block characteristicsTimepoint: To evaluate the block characteristics at baseline, day 1 & day 2 post operatively—

Countries

India

Contacts

Public ContactJalumuru kasi Nikhil

Sri Devaraj urs academy of higher education and research

Ravibabujalumuru@gmail.com9008909768

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026